Related Experiment Videos
Double-blind trial of flumazenil in hemiballismus
J Kulisevsky1, A Avila, M L Berthier
1Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Spain.
Clinical Neuropharmacology
|October 1, 1994
Abstract:
Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.